Decibel Therapeutics to Present DB-020 Phase 1b Clinical Tri

Data from interim analysis support DB-020 as a potential therapy to protect patients against irreversible hearing loss ...

Related Keywords

Boston , Massachusetts , United States , Chicago , Illinois , American , Chris Railey , Julie Seidel , John Lee , American Society Of Clinical Oncology , Stern Ir Inc , Twitter , Exchange Commission , American Society , Clinical Oncology , Annual Meeting , Chief Development Officer , Neck Cancer , Metastatic Disease , Decibel Therapeutics , Private Securities Litigation Reform Act , Quarterly Report , 新浪香港 , 新浪 , 新浪網 , 香港 , Sina , Sina Com Hk , Hong Kong ,